Published in Int J Neuropsychopharmacol on April 15, 2010
Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders. ACS Chem Neurosci (2014) 0.98
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat (2013) 0.95
Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies. BMC Med (2015) 0.93
Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis. Mol Psychiatry (2015) 0.93
A new avenue for lithium: intervention in traumatic brain injury. ACS Chem Neurosci (2014) 0.88
Inflammatory mediators of cognitive impairment in bipolar disorder. J Psychiatr Res (2014) 0.83
Prophylactic lithium treatment and cognitive performance in patients with a long history of bipolar illness: no simple answers in complex disease-treatment interplay. Int J Bipolar Disord (2014) 0.81
Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study. ACS Chem Neurosci (2014) 0.81
Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis. BMC Psychiatry (2013) 0.81
Lithium's role in neural plasticity and its implications for mood disorders. Acta Psychiatr Scand (2013) 0.78
Normal Metabolic Levels in Prefrontal Cortex in Euthymic Bipolar I Patients with and without Suicide Attempts. Neural Plast (2015) 0.76
Kidney, thyroid and other organ functions after 40 years or more of lithium therapy: a case series of five patients. Ther Adv Psychopharmacol (2016) 0.76
Response to lithium in bipolar disorder: clinical and genetic findings. ACS Chem Neurosci (2014) 0.76
Could selenium administration alleviate the disturbances of blood parameters caused by lithium administration in rats? Biol Trace Elem Res (2014) 0.75
Sex dependence of cognitive functions in bipolar disorder. ScientificWorldJournal (2014) 0.75
Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin Neurosci (2006) 1.01
Impairment of endothelial function in unipolar and bipolar depression. Biol Psychiatry (2006) 0.99
Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression. J Affect Disord (2012) 0.89
Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients. Pharmacogenomics (2008) 0.88
Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved? Hum Psychopharmacol (2012) 0.88
Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients. World J Biol Psychiatry (2006) 0.88
Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia. Schizophr Res (2009) 0.85
Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes. Am J Med Genet B Neuropsychiatr Genet (2007) 0.85
No association of three GRIN2B polymorphisms with lithium response in bipolar patients. Pharmacol Rep (2009) 0.84
Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders. Bipolar Disord (2010) 0.82
Types of depression more frequent in bipolar than in unipolar affective illness: results of the Polish DEP-BI study. Psychopathology (2007) 0.80
Bipolar or unipolar? - the question for clinicians and researchers. J Affect Disord (2006) 0.80
The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients. Hum Psychopharmacol (2009) 0.79
Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy. J Psychopharmacol (2011) 0.79
Prophylactic effect of lithium in bipolar affective illness may be related to serotonin transporter genotype. Pharmacol Rep (2005) 0.79
Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients. Neuro Endocrinol Lett (2011) 0.78
Functional -1149 g/t polymorphism of the prolactin gene in schizophrenia. Neuropsychobiology (2011) 0.78
Screening for the markers of kidney damage in men and women on long-term lithium treatment. Med Sci Monit (2012) 0.78
Treatment of depression in first episode of schizophrenia: results from EUFEST. Eur Neuropsychopharmacol (2012) 0.78
Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients. Hum Psychopharmacol (2011) 0.78
Bipolar mood disorders among Polish psychiatric outpatients treated for major depression. J Affect Disord (2005) 0.78
Long-term administration of the low-dose risperidone in schizotaxia subjects. Hum Psychopharmacol (2007) 0.77
Bipolar mood disorder, creativity and schizotypy: an experimental study. Psychopathology (2011) 0.77
Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients. Pharmacol Rep (2005) 0.76
[Bipolarity among unipolar affective disorder patients--uniDEP-BI national multi-site study]. Psychiatr Pol (2005) 0.75
[Frequency of bipolar affective disorders among depressive outpatients treated by psychiatrists]. Psychiatr Pol (2004) 0.75
[Bipolar and related disorders and depressive disorders in DSM-5]. Psychiatr Pol (2014) 0.75
[The probability of bipolarity among patients with recurrent depressive disorder]. Psychiatr Pol (2006) 0.75